| J9271 | Injection, pembrolizumab, 1 mg | 9,600 | $40 | $412.8K |
| J0897 | Injection, denosumab, 1 mg | 11,640 | $20 | $209.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,170 | $100 | $117.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 400 | $120 | $46.4K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 410 | $100 | $42.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 290 | $150 | $41.9K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 29,250 | $1 | $29.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 360 | $70 | $25.2K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,500 | $10 | $21K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,300 | $1 | $20.6K |